Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
17 | 48215561 | intron variant | C/T | snv | 0.72 |
|
0.700 | 1.000 | 4 | 2015 | 2018 | ||||||||||
|
0.882 | 0.120 | 17 | 48334138 | intron variant | A/G | snv | 0.34 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.700 | 1.000 | 2 | 2010 | 2013 | |||||||
|
0.882 | 0.120 | 17 | 48334138 | intron variant | A/G | snv | 0.34 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.700 | 1.000 | 2 | 2010 | 2013 | |||||||
|
17 | 48150484 | intron variant | C/T | snv | 0.16 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
17 | 48150484 | intron variant | C/T | snv | 0.16 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
17 | 48150484 | intron variant | C/T | snv | 0.16 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
17 | 48150484 | intron variant | C/T | snv | 0.16 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
17 | 48193244 | intron variant | T/C | snv | 6.1E-02 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
17 | 48228765 | intron variant | T/A | snv | 0.14 |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||||
|
17 | 48153529 | intron variant | C/T | snv | 0.12 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
17 | 48174984 | intron variant | T/C | snv | 0.94 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.925 | 0.080 | 17 | 48184809 | missense variant | C/T | snv | 4.0E-06; 0.63 | 0.55 |
|
Female Urogenital Diseases and Pregnancy Complications | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||||
|
0.925 | 0.080 | 17 | 48184809 | missense variant | C/T | snv | 4.0E-06; 0.63 | 0.55 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||||
|
0.925 | 0.120 | 17 | 48423311 | intron variant | T/C | snv | 0.33 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.120 | 17 | 48423311 | intron variant | T/C | snv | 0.33 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
17 | 48160646 | intron variant | A/G | snv | 1.3E-02 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.925 | 0.040 | 17 | 48262165 | intron variant | T/G | snv | 3.0E-02 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.925 | 0.040 | 17 | 48262165 | intron variant | T/G | snv | 3.0E-02 |
|
Musculoskeletal Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.080 | 17 | 48216874 | intron variant | C/A | snv | 0.52 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.882 | 0.120 | 17 | 48334138 | intron variant | A/G | snv | 0.34 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2015 | 2015 |